Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
Status:
Not yet recruiting
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
1. To evaluate the efficacy of Songling Xuemaikang Capsules(SLXMKC) with grade 1
hypertension.
2. To reveal the potiential effects of SLXMKC on vascular function and structure of
patients with grade 1 hypertension.
3. To explore the underlying mechanisms of the therapeutic effects of SLXMKC on the
intervention of grade 1 hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Collaborators:
China Academy of Chinese Medical Sciences Xiyuan Hospital Jining Hospital Shandong University of Traditional Chinese Medicine Suzhou Hosptial of Traditional Chinese Medicine